BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Valls C, Cos M, Figueras J, Andía E, Ramos E, Sánchez A, Serrano T, Torras J. Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual-phase helical CT. AJR Am J Roentgenol. 2004;182:1011-1017. [PMID: 15039179 DOI: 10.2214/ajr.182.4.1821011] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Liu YI, Kamaya A, Jeffrey RB, Shin LK. Multidetector Computed Tomography Triphasic Evaluation of the Liver Before Transplantation: Importance of Equilibrium Phase Washout and Morphology for Characterizing Hypervascular Lesions. Journal of Computer Assisted Tomography 2012;36:213-9. [DOI: 10.1097/rct.0b013e318247c8f0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
2 Lencioni R, Piscaglia F, Bolondi L. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. Journal of Hepatology 2008;48:848-57. [DOI: 10.1016/j.jhep.2008.02.005] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 5.3] [Reference Citation Analysis]
3 Lencioni R, Della Pina C, Cioni D, Crocetti L. Guidelines for the use of contrast-enhanced ultrasound in hepatocellular carcinoma. European Journal of Cancer Supplements 2008;6:1-8. [DOI: 10.1016/j.ejcsup.2008.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, Venturi AM, Piscaglia F. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology. 2005;42:27-34. [PMID: 15954118 DOI: 10.1002/hep.20728] [Cited by in Crossref: 308] [Cited by in F6Publishing: 270] [Article Influence: 18.1] [Reference Citation Analysis]
5 Laghi A, Sansoni I, Celestre M, Paolantonio P, Passariello R. Computed Tomography. In: Lencioni R, Cioni D, Bartolozzi C, editors. Focal Liver Lesions. Berlin/Heidelberg: Springer-Verlag; 2005. pp. 17-32. [DOI: 10.1007/3-540-26354-3_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Chou CT, Chen RC, Lee CW, Ko CJ, Wu HK, Chen YL. Prediction of microvascular invasion of hepatocellular carcinoma by pre-operative CT imaging. Br J Radiol 2012;85:778-83. [PMID: 21828149 DOI: 10.1259/bjr/65897774] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
7 Quaia E, D'Onofrio M, Cabassa P, Vecchiato F, Caffarri S, Pittiani F, Wittkowski KM, Cova MA. Diagnostic value of hepatocellular nodule vascularity after microbubble injection for characterizing malignancy in patients with cirrhosis. AJR Am J Roentgenol 2007;189:1474-83. [PMID: 18029888 DOI: 10.2214/AJR.07.2122] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
8 Caraiani C, Boca B, Bura V, Sparchez Z, Dong Y, Dietrich C. CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017-Can Things Be Put Together? Biology (Basel) 2021;10:412. [PMID: 34066607 DOI: 10.3390/biology10050412] [Reference Citation Analysis]
9 Kitzing YX, Ng BH, Kitzing B, Waugh R, Kench JG, Strasser SI, Mccormack S. Washout of hepatocellular carcinoma on portal venous phase of multidetector computed tomography in a pre-transplant population: Portal venous phase washout of HCCs. Journal of Medical Imaging and Radiation Oncology 2015;59:673-80. [DOI: 10.1111/1754-9485.12347] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
10 Bendik E, Noël PB, Münzel D, Fingerle AA, Henninger M, Markus C, Vlassenbroek A, Rummeny EJ, Dobritz M. Evaluation of a method for improving the detection of hepatocellular carcinoma. Eur Radiol 2014;24:250-5. [PMID: 23996016 DOI: 10.1007/s00330-013-3006-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
11 Chernyak V, Kobi M, Flusberg M, Fruitman KC, Sirlin CB. Effect of threshold growth as a major feature on LI-RADS categorization. Abdom Radiol 2017;42:2089-100. [DOI: 10.1007/s00261-017-1105-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
12 Torrisi C, Picone D, Cabibbo G, Matranga D, Midiri M, Brancatelli G. Gadoxetic acid-enhanced MRI of transient hepatic enhancement differences: Another cause of hypointense observation on hepatobiliary phase. Eur J Radiol 2018;107:39-45. [PMID: 30292271 DOI: 10.1016/j.ejrad.2018.08.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Solorio L, Exner AA. Applications of ultrasound for image-guided drug delivery in cancer chemotherapy. Ther Deliv 2013;4:785-9. [PMID: 23883123 DOI: 10.4155/tde.13.49] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Furlan A, Marin D, Vanzulli A, Patera GP, Ronzoni A, Midiri M, Bazzocchi M, Lagalla R, Brancatelli G. Hepatocellular carcinoma in cirrhotic patients at multidetector CT: hepatic venous phase versus delayed phase for the detection of tumour washout. Br J Radiol 2011;84:403-12. [PMID: 21081569 DOI: 10.1259/bjr/18329080] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
15 Maluf DG, Stravitz RT, Williams B, Cotterell AH, Mas VR, Heuman D, Luketic V, Shiffman ML, Sterling R, Posner MP, Fisher RA. Multimodality therapy and liver transplantation in patients with cirrhosis and hepatocellular carcinoma: 6 years, single-center experience. Transplant Proc 2007;39:153-9. [PMID: 17275495 DOI: 10.1016/j.transproceed.2006.10.029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
16 Mazzoccoli G, Tarquini R, Valoriani A, Oben J, Vinciguerra M, Marra F. Management strategies for hepatocellular carcinoma: old certainties and new realities. Clin Exp Med 2016;16:243-56. [PMID: 26077653 DOI: 10.1007/s10238-015-0368-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
17 Solorio L, Patel RB, Wu H, Krupka T, Exner AA. Advances in image-guided intratumoral drug delivery techniques. Ther Deliv 2010;1:307-22. [PMID: 22816134 DOI: 10.4155/tde.10.20] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
18 Luca A, Caruso S, Milazzo M, Mamone G, Marrone G, Miraglia R, Maruzzelli L, Carollo V, Minervini MI, Vizzini G, Grutttadauria S, Gridelli B. Multidetector-row computed tomography (MDCT) for the diagnosis of hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological correlation with liver explants. Eur Radiol 2010;20:898-907. [DOI: 10.1007/s00330-009-1622-0] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
19 Meyer BC, Frericks BB, Voges M, Borchert M, Martus P, Justiz J, Wolf KJ, Wacker FK. Visualization of hypervascular liver lesions During TACE: comparison of angiographic C-arm CT and MDCT. AJR Am J Roentgenol. 2008;190:W263-W269. [PMID: 18356419 DOI: 10.2214/ajr.07.2695] [Cited by in Crossref: 57] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
20 Murakami T, Tsurusaki M, Hyodo T, Imai Y. Clinical utility of imaging for evaluation of hepatocellular carcinoma. J Hepatocell Carcinoma 2014;1:101-8. [PMID: 27508179 DOI: 10.2147/JHC.S48602] [Reference Citation Analysis]
21 Schindera ST, Nelson RC, Mukundan S, Paulson EK, Jaffe TA, Miller CM, Delong DM, Kawaji K, Yoshizumi TT, Samei E. Hypervascular Liver Tumors: Low Tube Voltage, High Tube Current Multi–Detector Row CT for Enhanced Detection—Phantom Study. Radiology 2008;246:125-32. [DOI: 10.1148/radiol.2461070307] [Cited by in Crossref: 148] [Cited by in F6Publishing: 120] [Article Influence: 10.6] [Reference Citation Analysis]
22 Lencioni R, Crocetti L, Della Pina MC, Cioni D. Guidelines for imaging focal lesions in liver cirrhosis. Expert Review of Gastroenterology & Hepatology 2014;2:697-703. [DOI: 10.1586/17474124.2.5.697] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
23 Lee JD, Kang WJ, Yun M. Primary Cancer of the Liver and Biliary Duct. PET Clin 2008;3:169-86. [PMID: 27156461 DOI: 10.1016/j.cpet.2008.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
24 Horowitz JM, Kamel IR, Arif-tiwari H, Asrani SK, Hindman NM, Kaur H, Mcnamara MM, Noto RB, Qayyum A, Lalani T. ACR Appropriateness Criteria ® Chronic Liver Disease. Journal of the American College of Radiology 2017;14:S391-405. [DOI: 10.1016/j.jacr.2017.08.045] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
25 Sherman M. What is the long-term efficacy of percutaneous ethanol injection for small hepatocellular carcinoma? Nat Clin Pract Gastroenterol Hepatol 2006;3:78-9. [PMID: 16456573 DOI: 10.1038/ncpgasthep0408] [Reference Citation Analysis]
26 Layer G, Delorme S. [Radiological diagnosis of hepatic tumors. Part II: Identification and differential diagnosis]. Radiologe 2007;47:919-31; quiz 932-3. [PMID: 17898982 DOI: 10.1007/s00117-007-1564-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Nadarevic T, Giljaca V, Colli A, Fraquelli M, Casazza G, Miletic D, Štimac D. Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database Syst Rev 2021;10:CD013362. [PMID: 34611889 DOI: 10.1002/14651858.CD013362.pub2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Arrivé L, Rosmorduc O, Azizi L, Monnier-cholley L, Lewin M, Beaussier M, Tubiana J. A new technique for localization of hepatic tumors that are poorly visible with CT fluoroscopy. Eur Radiol 2006;16:2811-6. [DOI: 10.1007/s00330-006-0231-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Hirakawa M, Yoshimitsu K, Irie H, Tajima T, Nishie A, Asayama Y, Ishigami K, Kakihara D, Taketomi A, Aishima S, Honda H. Performance of radiological methods in diagnosing hepatocellular carcinoma preoperatively in a recipient of living related liver transplantation: comparison with step section histopathology. Jpn J Radiol 2011;29:129-37. [DOI: 10.1007/s11604-010-0528-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
30 Sherman M. Approaches to the diagnosis of hepatocellular carcinoma. Curr Gastroenterol Rep 2005;7:11-8. [DOI: 10.1007/s11894-005-0060-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
31 Pompili M, Riccardi L, Semeraro S, Orefice R, Elia F, Barbaro B, Covino M, Grieco A, Gasbarrini G, Rapaccini GL. Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver. Dig Liver Dis. 2008;40:206-215. [PMID: 18054850 DOI: 10.1016/j.dld.2007.10.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
32 Denecke T, Grieser C, Fröling V, Steffen IG, Rudolph B, Stelter L, Lehmkuhl L, Streitparth F, Langrehr J, Neuhaus P. Multislice computed tomography using a triple-phase contrast protocol for preoperative assessment of hepatic tumor load in patients with hepatocellular carcinoma before liver transplantation. Transpl Int. 2009;22:395-402. [PMID: 19000231 DOI: 10.1111/j.1432-2277.2008.00793.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
33 Beadsmoore CJ, Cheow HK, Sala E, Lomas DJ, Gibbs P, Save V, Alison ME, Balan KK. Hepatocellular carcinoma tumour thrombus in a re-canalised para-umbilical vein: detection by 18-fluoro-2-deoxyglucose positron emission tomography imaging. Br J Radiol. 2005;78:841-844. [PMID: 16110108 DOI: 10.1259/bjr/37052159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
34 Ronzoni A, Artioli D, Scardina R, Battistig L, Minola E, Sironi S, Vanzulli A. Role of MDCT in the diagnosis of hepatocellular carcinoma in patients with cirrhosis undergoing orthotopic liver transplantation. AJR Am J Roentgenol 2007;189:792-8. [PMID: 17885047 DOI: 10.2214/AJR.07.2040] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
35 Balci NC, Befeler AS, Bieneman BK, Fattahi R, Saglam S, Havlioglu N. Fat containing HCC: findings on CT and MRI including serial contrast-enhanced imaging. Acad Radiol. 2009;16:963-968. [PMID: 19386514 DOI: 10.1016/j.acra.2009.02.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
36 Cerny M, Bergeron C, Billiard JS, Murphy-Lavallée J, Olivié D, Bérubé J, Fan B, Castel H, Turcotte S, Perreault P, Chagnon M, Tang A. LI-RADS for MR Imaging Diagnosis of Hepatocellular Carcinoma: Performance of Major and Ancillary Features. Radiology 2018;288:118-28. [PMID: 29634435 DOI: 10.1148/radiol.2018171678] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 14.8] [Reference Citation Analysis]
37 Hu J, Xu Y, Shen ZZ, Wang Z, Lu Q, Yang GH, Ding ZB, Fan J, Zhou J. High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection. J Cancer Res Clin Oncol. 2009;135:1359-1367. [PMID: 19350273 DOI: 10.1007/s00432-009-0577-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
38 Kamaya A, Maturen KE, Tye GA, Liu YI, Parti NN, Desser TS. Hypervascular Liver Lesions. Seminars in Ultrasound, CT and MRI 2009;30:387-407. [DOI: 10.1053/j.sult.2009.06.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
39 Golfieri R, Coppola F, Fusco F, Li Bassi S, Caraceni P, Bernardi M, Trevisani F. Malignant progression of a small HCC nodule: hypovascular 'early HCC' converted to hypervascular 'small HCC' within six months. Dig Liver Dis 2007;39:883-90. [PMID: 17045857 DOI: 10.1016/j.dld.2006.09.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
40 Kim KS, Lee JM, Kim SH, Kim KW, Kim SJ, Cho SH, Han JK, Choi BI. Image Fusion in Dual Energy Computed Tomography for Detection of Hypervascular Liver Hepatocellular Carcinoma: Phantom and Preliminary Studies. Investigative Radiology 2010;45:149-57. [DOI: 10.1097/rli.0b013e3181d32119] [Cited by in Crossref: 62] [Cited by in F6Publishing: 20] [Article Influence: 5.2] [Reference Citation Analysis]
41 Mas VR, Maluf DG, Archer KJ, Yanek K, Williams B, Fisher RA. Differentially expressed genes between early and advanced hepatocellular carcinoma (HCC) as a potential tool for selecting liver transplant recipients. Mol Med 2006;12:97-104. [PMID: 16953559 DOI: 10.2119/2006-00032.Mas] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
42 Oto A, Tamm EP, Szklaruk J. Multidetector Row CT of the Liver. Radiologic Clinics of North America 2005;43:827-48. [DOI: 10.1016/j.rcl.2005.05.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
43 Hidaka M, Eguchi S, Okudaira S, Takatsuki M, Tokai H, Soyama A, Nagayoshi S, Mochizuki S, Hamasaki K, Tajima Y, Kanematsu T. Multicentric occurrence and spread of hepatocellular carcinoma in whole explanted end-stage liver. Hepatology Research 2009;39:143-8. [DOI: 10.1111/j.1872-034x.2008.00443.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
44 Aljabiri MR, Lodato F, Burroughs AK. Surveillance and diagnosis for hepatocellular carcinoma. Liver Transpl 2007;13:S2-S12. [DOI: 10.1002/lt.21324] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
45 Hanna RF, Kased N, Kwan SW, Gamst AC, Santosa AC, Hassanein T, Sirlin CB. Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis. AJR Am J Roentgenol. 2008;190:47-57. [PMID: 18094293 DOI: 10.2214/ajr.07.2595] [Cited by in Crossref: 39] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
46 Sorrentino P, Tarantino L, D’Angelo S, Terracciano L, Ferbo U, Bracigliano A, Panico L, De Chiara G, Lepore M, De Stefano N. Validation of an extension of the international non-invasive criteria for the diagnosis of hepatocellular carcinoma to the characterization of macroscopic portal vein thrombosis. J Gastroenterol Hepatol. 2011;26:669-677. [PMID: 21054520 DOI: 10.1111/j.1440-1746.2010.06564.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
47 Nakamura Y, Tashiro H, Nambu J, Ohdan H, Kakizawa H, Date S, Awai K. Detectability of hepatocellular carcinoma by gadoxetate disodium-enhanced hepatic MRI: tumor-by-tumor analysis in explant livers. J Magn Reson Imaging 2013;37:684-91. [PMID: 23055436 DOI: 10.1002/jmri.23855] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
48 Horowitz JM, Kamel IR, Arif-tiwari H, Asrani SK, Hindman NM, Kaur H, Mcnamara MM, Noto RB, Qayyum A, Lalani T. ACR Appropriateness Criteria ® Chronic Liver Disease. Journal of the American College of Radiology 2017;14:S103-17. [DOI: 10.1016/j.jacr.2017.02.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
49 Nicolau C, Bru C. Characterisation of Hepatocellular Carcinoma in Cirrhosis. In: Lencioni R, editor. Enhancing the Role of Ultrasound with Contrast Agents. Milan: Springer-Verlag; 2006. pp. 39-52. [DOI: 10.1007/88-470-0476-4_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Pleguezuelo M, Germani G, Marelli L, Xiruochakis E, Misseri M, Manousou P, Arvaniti V, Burroughs AK. Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2014;2:761-84. [DOI: 10.1586/17474124.2.6.761] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
51 Hanna RF, Ward TJ, Chow DS, Lagana SM, Moreira RK, Emond JC, Weintraub JL, Prince MR. An evaluation of the sensitivity of MRI at detecting hepatocellular carcinoma in cirrhotic patients utilizing an explant reference standard. Clinical Imaging 2014;38:693-7. [DOI: 10.1016/j.clinimag.2014.05.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
52 Sørensen M, Frisch K, Bender D, Keiding S. The potential use of 2-[18F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2011;38:1723-1731. [PMID: 21553087 DOI: 10.1007/s00259-011-1831-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
53 Addley HC, Griffin N, Shaw AS, Mannelli L, Parker RA, Aitken S, Wood H, Davies S, Alexander GJ, Lomas DJ. Accuracy of hepatocellular carcinoma detection on multidetector CT in a transplant liver population with explant liver correlation. Clin Radiol. 2011;66:349-356. [PMID: 21295772 DOI: 10.1016/j.crad.2010.11.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
54 Casanovas-Taltavull T, Ribes J, Berrozpe A, Jordan S, Casanova A, Sancho C, Valls C, Bosch FX. Patient with hepatocellular carcinoma related to prior acute arsenic intoxication and occult HBV: Epidemiological, clinical and therapeutic results after 14 years of follow-up. World J Gastroenterol 2006; 12(12): 1972-1974 [PMID: 16610011 DOI: 10.3748/wjg.v12.i12.1972] [Reference Citation Analysis]
55 Ramos E, Lladó L, Serrano T, Figueras A, Lastra R, Torras J, Figueras J, Rafecas A, Fabregat J. Utility of Cell-cycle Modulators to Predict Vascular Invasion and Recurrence After Surgical Treatment of Hepatocellular Carcinoma. Transplantation 2006;82:753-8. [DOI: 10.1097/01.tp.0000234718.40266.75] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
56 Quaia E, Alaimo V, Baratella E, Medeot A, Midiri M, Cova MA. The added diagnostic value of 64-row multidetector CT combined with contrast-enhanced US in the evaluation of hepatocellular nodule vascularity: implications in the diagnosis of malignancy in patients with liver cirrhosis. Eur Radiol. 2009;19:651-663. [PMID: 18815790 DOI: 10.1007/s00330-008-1179-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
57 Tang A, Bashir MR, Corwin MT, Cruite I, Dietrich CF, Do RKG, Ehman EC, Fowler KJ, Hussain HK, Jha RC, Karam AR, Mamidipalli A, Marks RM, Mitchell DG, Morgan TA, Ohliger MA, Shah A, Vu KN, Sirlin CB; LI-RADS Evidence Working Group. Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review. Radiology 2018;286:29-48. [PMID: 29166245 DOI: 10.1148/radiol.2017170554] [Cited by in Crossref: 131] [Cited by in F6Publishing: 128] [Article Influence: 26.2] [Reference Citation Analysis]
58 Doyle DJ, O'Malley ME, Jang HJ, Jhaveri K. Value of the unenhanced phase for detection of hepatocellular carcinomas 3 cm or less when performing multiphase computed tomography in patients with cirrhosis. J Comput Assist Tomogr 2007;31:86-92. [PMID: 17259838 DOI: 10.1097/01.rct.0000233126.21303.f0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
59 Choi YR, Chung JW, Yu MH, Lee M, Kim JH. Diagnostic accuracy of contrast-enhanced dynamic CT for small hypervascular hepatocellular carcinoma and assessment of dynamic enhancement patterns: Results of two-year follow-up using cone-beam CT hepatic arteriography. PLoS One. 2018;13:e0203940. [PMID: 30231076 DOI: 10.1371/journal.pone.0203940] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
60 Kanal KM, Chung JH, Wang J, Bhargava P, Kohr JR, Shuman WP, Stewart BK. Image Noise and Liver Lesion Detection With MDCT: A Phantom Study. American Journal of Roentgenology 2011;197:437-41. [DOI: 10.2214/ajr.10.5726] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
61 Andreana L, Isgrò G, Pleguezuelo M, Germani G, Burroughs AK. Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis. World J Hepatol 2009; 1(1): 48-61 [PMID: 21160965 DOI: 10.4254/wjh.v1.i1.48] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
62 Herber SC, Otto G, Schneider J, Schuchmann M, Düber C, Pitton MB, Kummer I, Manzl N. Transarterial chemoembolization in patients not eligible for liver transplantation: single-center results. AJR Am J Roentgenol. 2008;190:1035-1042. [PMID: 18356452 DOI: 10.2214/ajr.07.2755] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
63 Ohto M, Ito R, Soma N, Fukuda H, Shinohara Y, Sakamoto A, Kondo F. Contrast-enhanced 3D ultrasonography in minute hepatocellular carcinoma. J Med Ultrason (2001) 2011;38:3-12. [PMID: 27278332 DOI: 10.1007/s10396-010-0283-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
64 Macarini L, Milillo P, Cascavilla A, Scalzo G, Stoppino L, Vinci R, Moretti G, Ettorre G. MR characterisation of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: pathological correlation in explanted livers. Radiol med 2009;114:1267-82. [DOI: 10.1007/s11547-009-0464-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
65 Thompson Coon J, Rogers G, Hewson P, Wright D, Anderson R, Jackson S, Ryder S, Cramp M, Stein K. Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis. Br J Cancer. 2008;98:1166-1175. [PMID: 18382459 DOI: 10.1038/sj.bjc.6604301] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 5.3] [Reference Citation Analysis]
66 Santillan CS, Tang A, Cruite I, Shah A, Sirlin CB. Understanding LI-RADS: a primer for practical use. Magn Reson Imaging Clin N Am 2014;22:337-52. [PMID: 25086933 DOI: 10.1016/j.mric.2014.04.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
67 Alba E, Valls C, Dominguez J, Martinez L, Escalante E, Lladó L, Serrano T. Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma on the waiting list for orthotopic liver transplantation. AJR Am J Roentgenol. 2008;190:1341-1348. [PMID: 18430853 DOI: 10.2214/ajr.07.2972] [Cited by in Crossref: 50] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]